Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Busse WW, Lemanske RF. Advances in immunology: asthma. N Engl J Med 2001; 344(5): 350–62
Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leukoc Biol 1995; 58: 373–81
Clot J. Pharmacology of ribosomal immunotherapy. Drugs 1997; 54 Suppl. 1: 33–6
Boccacio C, Jacod S, Kaiser A, et al. Identification of a clinical-grade maturation factor for dendritic cells. J Immunother 2002; 25(1): 88–96
DuPan MRE, Koechli B. Interferon induction by the bacterial lysate Broncho-vaxom: a double-blind clinical study in children. Kinderarzt 1984; 15: 646–51
McDyer JF, Wu CHY, Seder RA. The regulation of IL-12: its role in infectious, autoimmune and allergic diseases. J Allergy Clin Immunol 1998; 102: 11–5
Fulton SA, Johnsen JM, Wolf SF. Interleukin 12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996; 64: 2523–31
Spisek R, Brazova J, Rozkova D, et al. Maturation of dendritic cells by bacterial imunomodulators. Vaccine 2004; 29:(21–22): 2761–8
Meroni PL, Barcellini W, Sguotti C. Immunomodulating activity of RU 41740: in vitro and in vivo studies on human lymphocytes. Int J Immunopharmacol 1987; 9: 185–90
Hoekstra MO, Hoekstra Y, de Reus D, et al. Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate asthma. Clin Exp Allergy 1997; 27: 1254–60
Tang MLK, Coleman J, Kemp AS. Interleukin-4 and interferon-gamma production in atopic a nonatopic children with asthma. Clin Exp Allergy 1994; 25: 515–21
Hesselmar B, Aberg B, Aberg B, et al. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1998; 29: 611–7
Liu AH, Leung DYM. Modulating the early allergic response with endotoxin. Clin Exp Allergy 2000; 30: 1230–4
Svanes C, Jarvis D, Chinn S, et al. Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 103: 415–20
VonMuttius E, Braun-Fahrlander C, Schirl R, et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000; 30: 1230–539
Eldrige MW, Peden DB. Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2000; 105: 475–81
Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989; 66: 1059–64
Michel O, Kips J, Duchateau J, et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154: 1641–6
Tulic MK, Wale JL, Holt PG, et al. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysacharide. Am J Respir Cell Mol Biol 2000; 22: 604–12
Creticos PS, Eiden JJ, Blacer SL, et al. Immunostimulatory oligonucleotides conjugated to Amb a 1: safety, skin test reactivity and basophil histamine realse [abstract]. J Allergy Clin Immunol 2000; 105: S70
Acknowledgements
This study was funded by Pierre Fabre Médicament, France. The authors have provided no information on conflicts of interest directly relevant to the content of this study.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bystroň, J., Heřmanová, Z., Szotkovská, J. et al. Comparison of the Effect of Ribosomal Immunotherapy on Plasma Levels of Total IgE and Cytokines IL-4, IL-5, IL-12 and IFNγ in Adult Atopic and Non-Atopic Patients during the Pollen Season. Clin. Drug Investig. 24, 755–760 (2004). https://doi.org/10.2165/00044011-200424120-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-200424120-00007